Kimura T, Saunders P A, Yamamoto I, Ho I K
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505.
Neurochem Res. 1991 Oct;16(10):1133-7. doi: 10.1007/BF00966591.
Effects of pentobarbital pellet implantation on [3H]baclofen binding in the frontal cortex of cerebellum of rat brains were examined. In the frontal cortex, pentobarbital tolerance caused an increase in the number of binding sites (Bmax) without changing their affinity (KD). Twenty-four hours after withdrawal of the pentobarbital pellets, there was a significant increase in the KD and Bmax values. Cerebellar binding, in contrast, was not significantly changed in any of the treatment groups. Addition of 1 mM of pentobarbital directly to binding assays using cortical membrane produced as increase in KD without a change in Bmax. In vitro, pentobarbital affected neither the KD nor the Bmax in the cerebellar [3H]baclofen binding. These results suggest that like the GABAA receptor, [3H]baclofen binding to the GABAB receptor in rat frontal cortex was affected by pentobarbital tolerance and dependence, and that there are regional differences in the properties of the GABAB receptor.
研究了戊巴比妥微丸植入对大鼠脑小脑额叶皮质中[³H]巴氯芬结合的影响。在额叶皮质中,戊巴比妥耐受性导致结合位点数量(Bmax)增加,而其亲和力(KD)未发生变化。取出戊巴比妥微丸24小时后,KD和Bmax值显著增加。相比之下,在任何治疗组中,小脑结合均无显著变化。在使用皮质膜的结合试验中直接添加1 mM戊巴比妥会导致KD增加,而Bmax不变。在体外,戊巴比妥对小脑[³H]巴氯芬结合的KD和Bmax均无影响。这些结果表明,与GABAA受体一样,大鼠额叶皮质中[³H]巴氯芬与GABAB受体的结合受戊巴比妥耐受性和依赖性的影响,并且GABAB受体的特性存在区域差异。